Close menu




October 14th, 2020 | 11:40 CEST

BioNTech, BIGG, Bitcoin - The traffic lights are green!

  • Investments
Photo credits: pixabay.com

A trend is present when the price of security tends to move in a specific direction, even under fluctuation. To play this trend correctly and to make more significant price gains, one should recognize the signals of a trend reversal. With Bitcoin & Co., this could soon be the case. The stabilization phase is still underway, but buying pressure has increased in the last few days. Companies that have a unique position in the crypto market could benefit from this.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA0898041086 , US09075V1026

Table of contents:


    Right on target

    The Mainz-based vaccine company BioNTech can report further positive news. Approximately 1.5 million doses of the Pfizer BioNTech vaccine, one of the most promising candidates in the competition for the first regulatory approval in Europe and the USA, have been ordered by the New Zealand government. According to the government in Wellington, the quantity is sufficient to protect around 750,000 people with double vaccination. Negotiations are also ongoing with other pharmaceutical companies to serve all 5 million residents.

    Bitcoin - Is the second wave coming?

    The world's leading cryptocurrency, which peaked at just under USD 20,000 at the end of 2017, then entered a more substantial correction phase. It fell below the USD 4,000 mark twice, in December 2018, and the Corona low in March 2020, but then recovered with high volatility.

    Since March, digital gold has been steadily moving northwards, with a support zone of over USD 10,000 recently established. If the prices fall below the high reached in August at almost USD 12,500, there will be a reversal of the bull trend, and the chances of attaining the all-time high would be quite realistic. However, if the support level falls below USD 10,000, the scenario mentioned would be invalid.

    Profiteers of the run

    In addition to other crypto-currencies such as Etherum, Ripple or various Altcoins, companies that deal with the topic of crypto-currencies would also benefit disproportionately here. The Canadian Company BIGG Digital Assets Inc. believes that the future of crypto-currencies depends on a secure and regulated environment.

    In this context, the Blockchain Intelligence Group division provides search and analysis tools. The developed product "QLUE" is used by law enforcement agencies, banks, stock exchanges, and ATM operators to conduct due diligence investigations and block the security chain. With greater forensic depth, it examines where the funds in question come from, where they are going, and the profiles of the agencies involved. At the end of September, BIGG was able to convince a federal agency in the United States to use the program. The license runs for one year and costs the agency CAD 320,000.

    Canada's first regulated trading platform

    In the second pillar, Netcoins, a brokerage and stock exchange software is in development to make the buying and selling of cryptocurrency easily accessible to mass consumers and investors, with a focus on compliance and security. Just last month, Netcoins filed for registration with the British Columbia Securities Commission (BCSC) and the Canadian Securities Administrators (CSA), which, if approved, would allow Netcoins to operate the first regulated open-loop crypto-asset trading platform in Canada. For the young Company, this would be a huge milestone.

    Pioneering work offers enormous potential.

    BIGG CEO Mark Binns commented: "BIGG believes the future of crypto is a compliant, safe and regulated environment. It is the basis of existence for our company. Pending this regulatory approval, Netcoins will be the first registered open-loop crypto-trading platform in Canada. This will be a fundamental change for crypto trading in Canada. As individuals and corporations seek to trade crypto assets, they would have a fully legal and registered platform available to them. We also believe this will have a significant positive impact on Netcoins trading volumes in the coming months, being a unique competitive advantage. We look forward to updating our shareholders further with developments in the coming weeks."


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Juliane Zielonka on December 1st, 2022 | 10:44 CET

    Aspermont, Twitter, Apple - Strong numbers, strong visions and marketplace power

    • Digitization
    • Commodities
    • Investments

    The Australian media company for the commodities industry has presented its latest figures. The results are impressive, with total revenue up 17% YOY, among other things. This industry pioneer illustrates just how valuable access to high-quality information can be. Perhaps soon to disappear from the scene is Elon Musk's Twitter: Find out how strong its dependence on the App Store giant is and what impact Apple fees may have on its revenue model here.

    Read

    Commented by Fabian Lorenz on November 30th, 2022 | 13:31 CET

    Biotech stocks in focus: Morphosys, Evotec, Bayer, BioNxt Solutions

    • Biotechnology
    • Cancer
    • Investments

    Biotech stocks have struggled in 2022. In Germany, BioNTech has overtaken the previous heavyweights Morphosys and Evotec in record time. Morphosys shocked investors with data on its Alzheimer's hope. Analysts lowered their thumbs, and short-sellers discovered the stock for themselves. Evotec has been quiet this year. Analysts think the valuation is attractive, but meeting earnings guidance in the current year is not a given. BioNxt shares have jumped recently, and if the positive newsflow continues into 2023, a re-rating is possible. At Bayer, the pharmaceuticals division is also developing positively. Conclusion: investors should position themselves for the biotech year 2023.

    Read

    Commented by Stefan Feulner on November 29th, 2022 | 13:32 CET

    Nvidia, Meta Materials, SFC Energy - Strong signs

    • Technology
    • Investments
    • nanotechnology

    After turbulent months on the technology stock markets with high markdowns, a bottoming out is taking place across the board. While many companies are reporting better-than-expected figures, investors are also buying oversold companies whose quarterly figures were below analysts' consensus. Due to the still high fluctuation range, high trading profits can be expected.

    Read